Related Experiment Video
Updated: Apr 5, 2026

11:29
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Published on: October 3, 2012
11.3K
Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event
Victoria Lewis1, Vanessa A Johanssen2, Peter J Crouch2
1Department of Medicine, RMH, The University of Melbourne, Parkville, VIC, 3010, Australia.
Cellular and Molecular Life Sciences : CMLS
|August 24, 2015
Summary
Researchers discovered a new cellular prion protein (PrP(C)) fragment, C3, generated by gamma-cleavage. This previously overlooked processing event occurs in the secretory pathway and may be significant in prion diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- The cellular prion protein (PrP(C)) has diverse functions, with known processing via alpha- and beta-cleavage.
- These known cleavage events produce distinct fragments (N1/C1, N2/C2) potentially serving different cellular roles.
Purpose of the Study:
- To identify and characterize novel cleavage events of the cellular prion protein (PrP(C)).
- To investigate the mechanism and cellular localization of this new cleavage event.
Main Methods:
- Engineered a C-terminal c-myc tag onto murine PrP(C) for fragment identification.
- Utilized a far-C-terminal anti-PrP antibody to detect and characterize novel fragments.
- Investigated cleavage timing within the secretory pathway and at the cell surface.
Main Results:
- Identified a new PrP(C) fragment, C3, resulting from 'gamma-cleavage'.
- Gamma-cleavage occurs during transit through the secretory pathway and on the cell surface, mediated by matrix metalloproteases.
- C3 is GPI-anchored but does not primarily localize to the cell surface and is preferentially cleaved from unglycosylated PrP(C).
- C3 is found in various cell types and brain tissue, with potential increases in human prion diseases.
Conclusions:
- A novel gamma-cleavage event of PrP(C) producing fragment C3 has been identified.
- This cleavage occurs in the secretory pathway and on the cell surface, potentially involving matrix metalloproteases.
- The presence of C3 in diverse tissues and its potential link to prion diseases highlight the significance of this underappreciated PrP(C) processing pathway.
More Related Videos
Related Concept Videos
Protein Folding Quality Check in the RER
5.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
5.7K
Export of Misfolded Proteins out of the ER
5.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K
Amyloid Fibrils
13.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.0K
Amyloid Fibrils
7.0K
7.0K
The Proteasome
10.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.6K
The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K

